Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis

NCT04582084

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +21 more
Locations
  • Connective Diseases Research Center, Tabriz University of Medical Sciences Tabriz, East Azerbaijan Province, Iran
  • Hafez Hospital Shiraz, Fars, Iran
  • Razi Hospital Rasht, Gilan Province, Iran
  • Ghaem Hospital Mashhad, Khorasan, Iran
View Trial Details
Completed

A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation

NCT02988674

Conditions
Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +15 more
Locations
  • Kemerovo Regional Clinical Hospital n.a. S.V. Belyaev /ID# 167025 Kemerovo, Kemerovo Oblast, Russia
  • Clinical Hospital No.1 n.a. N.I.Pirogov /ID# 154379 Moscow, Russia
  • Ivanovo Regional Clinical Hosp /ID# 167028 Ivanovo, Russia
  • Institution KhMAO-Ugra /ID# 154381 Khanty-Mansiysk, Russia
View all 14 locations
View Trial Details
Completed

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

NCT02721966

Conditions
Arthritis, Arthritis, Psoriatic, Axial Psoratic Arthritis, +11 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Rousse, Bulgaria
View all 94 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03482011

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Univ of Connecticut Farmington, Connecticut, United States
  • Florida Academic Dermatology Centers Coral Gables, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • Forward Clinical Trials, Inc Tampa, Florida, United States
View all 69 locations
View Trial Details

Related conditions